# PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study

> **NCT05222087** · PHASE1 · RECRUITING · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 40 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** SoC systemic therapy

## Key facts

- **NCT ID:** NCT05222087
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-03
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05222087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05222087, "PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05222087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*